A biochip is a miniaturized device, typically the size of a microscope slide or smaller, that performs biological or chemical analyses using tiny sensors embedded on a solid surface. Think of it as a scaled-down laboratory where thousands of biological tests can happen simultaneously on a single chip. Biochips detect specific molecules like DNA, proteins, or antibodies by using biological probes attached to a substrate, then converting those biological interactions into readable signals.
How a Biochip Works
Every biochip has three core components: a substrate, a biological sensing layer, and a signal detection system. The substrate is the physical foundation, usually made from glass, silicon, or plastic. On top of that substrate sit thousands of tiny reaction zones, each between 10 and 250 micrometers in diameter. These zones contain biological probes: short strands of DNA, antibodies, proteins, or other molecules designed to latch onto a specific target.
When a biological sample (blood, saliva, or extracted DNA, for example) washes over the chip, molecules in the sample bind to their matching probes. This binding event triggers a detectable signal. In some biochips, fluorescent dyes light up when a match occurs, and a scanner reads the intensity of that glow at each spot. In others, the binding creates a measurable change in electrical current or impedance. The strength of the signal at each reaction zone tells you how much of a particular molecule was present in the sample.
Types of Biochips
DNA Microarrays
DNA microarrays are the most widely recognized type. These chips contain thousands of short DNA sequences (called probes) attached to a glass or silicon surface. To use one, researchers extract RNA from cells, convert it into a labeled form using fluorescent or biotin-tagged molecules, and wash it over the chip. Wherever the sample DNA matches a probe sequence, it locks into place through a process called hybridization. After washing away the unbound material, a scanner reads the fluorescence at each spot. The brightness corresponds to how actively a particular gene was being expressed in the original sample.
DNA microarrays are also used for genotyping, where the goal is identifying specific genetic variants. Short DNA probes complementary to each possible version of a gene are placed on the array, with the variant position right in the center of the probe where it has the greatest effect on whether binding occurs. This makes it possible to scan for thousands of genetic variations in a single test.
Protein Microarrays
Protein microarrays work on the same principle but use proteins or antibodies as the sensing layer instead of DNA. Analytical protein microarrays use well-characterized antibodies to detect whether a specific protein is present in a complex sample like blood serum. These chips have been used to identify disease biomarkers, profile immune responses, map protein-to-protein interactions, and screen for drug targets. They can also detect protein modifications involved in cell signaling, making them valuable tools in cancer research and autoimmune disease studies.
Lab-on-a-Chip Devices
Lab-on-a-chip technology takes the concept further by integrating sample preparation, chemical reactions, and signal detection into a single miniaturized device. These chips use networks of microscale channels, valves, mixers, and chambers to move nanoliter to microliter volumes of fluid through a complete testing workflow. The result is a device that can perform in minutes what traditionally took days in a full-scale laboratory, using far less sample and fewer chemical reagents. This makes them especially useful for point-of-care diagnostics, where a test needs to happen at the patient’s bedside or in a field clinic rather than a centralized lab.
How Biochips Are Made
Biochip manufacturing borrows heavily from the semiconductor industry. Photolithography, the same technique used to etch circuits onto computer chips, remains one of the primary routes to mass production. It uses light projected through a patterned mask to define microscale features on the chip surface with high precision.
Two newer methods are gaining ground. Soft lithography uses flexible stamps or molds to print patterns at throughputs of 100 to 1,000 square centimeters per hour, with feature sizes as small as 30 nanometers. Nanoimprint lithography physically presses a mold into the chip material, and a variation called roller nanoimprint lithography wraps the mold around a cylinder for continuous roll-to-roll processing. Because nanoimprint lithography requires relatively simple equipment and delivers both high resolution and high throughput (around 1,000 square centimeters per hour), it has emerged as one of the most promising methods for producing low-cost biochips at scale.
Biochips vs. Traditional Lab Tests
The most obvious advantage is speed. A microfluidic immunoassay can deliver results in about 10 minutes of dynamic incubation, compared to the standard 2-hour static incubation protocol used in conventional tests. In at least one direct comparison for antibody detection, that 10-minute microfluidic run produced fluorescence signals up to six times stronger than the traditional method, meaning it was not just faster but more sensitive.
Biochips also require dramatically smaller samples. Where a conventional blood test might need several milliliters, a microfluidic chip can work with nanoliter to microliter volumes. This matters for newborn screening, finger-prick diagnostics, and any situation where collecting large samples is impractical. Running thousands of tests simultaneously on a single chip also reduces the per-test cost of reagents and labor.
Implantable Biochips
One of the more striking applications is the implantable biochip for continuous health monitoring. Researchers have developed a battery-less implantable sensor that estimates blood glucose levels by measuring the electrical properties of subcutaneous tissue. In a study on pigs, the device tracked glucose concentrations ranging from 77 to 524 mg/dL with strong correlation to standard blood glucose reference values. The animals remained clinically healthy throughout the study, and postmortem exams showed no adverse effects from the implant.
Because the device draws power wirelessly from an external source rather than an internal battery, it could in principle last indefinitely. The implantation requires only minor surgery. For people with diabetes, this kind of technology represents a shift from reactive management (pricking your finger, seeing a number, then responding) to proactive management, where a continuous glucose trend lets you anticipate changes before they become dangerous.
Where the Biochip Market Is Headed
The global biochip market is valued at roughly $14.3 billion in 2025 and is projected to reach approximately $41.9 billion by 2034, growing at about 12.7% per year. The main forces driving that growth are the rising prevalence of chronic diseases like diabetes and cancer, increasing demand for personalized medicine, and continued advances in genomics technology. As biochips become cheaper and more portable, they are moving out of research laboratories and into clinics, pharmacies, and even homes, making rapid molecular-level testing accessible in settings where it was never practical before.